Company intelligence / Profile preview

Koken

Bunkyo-ku, Tokyo, Japan

Ownership: Private
Development stage: Other

Overview

Koken is a leading supplier of medical simulation models, silicone-based medical materials, and atelocollagen products used in regenerative medicine, cosmetics, and emerging nucleic acid drug delivery research. It provides commercial medical devices, cosmetic ingredients, and research products, with evidence of pre-clinical advances in nucleic acid delivery and tissue engineering using atelocollagen[1].

Therapeutic areas: OtherDermatology
Modalities: Collagen-based biomaterialsAtelocollagenMedical PlasticsPotentially Gene therapy delivery (Atelocollagen DSD)
Industry: Consumable Medical Devices

Partnerships

Academic and government joint development projectsunspecified commercial/industrial partners

Beyond the preview

Go deeper on Koken.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Koken.

Explore the full profile